AlphaCentric Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$615K Sell
2024
Q2
$1.63M Buy
2024
Q1
$832K Buy
2023
Q4
$814K Sell
2023
Q3
$1.04M Hold
2023
Q2
$1.2M Hold
2023
Q1
$941K Hold
2022
Q4
$796K Buy
2021
Q4
$1.2M Sell
2021
Q3
$1.22M Buy
2021
Q2
$329K Buy
2021
Q1
Sell
2020
Q4
$126K Sell
2020
Q3
$130K Buy